Top

AAA SIGNS-JUDY MANUFACTURING CO INC

UEI: G642ZU17FLK8

AAA SIGNS-JUDY MANUFACTURING CO INC is a federal contractor, registered under UEI G642ZU17FLK8. It has been awarded $1,797 across 1 federal contract. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

G642ZU17FLK8

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

All time

Active

Currently performing

Completed

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Export

Department Of Veterans Affairs$1.8K100%

Awards by NAICS

Export

- Unknown NAICS$1.8K100%

Awards by Agency Over Time

Export

Awards by Place of Performance

Open opportunities in AAA SIGNS-JUDY MANUFACTURING CO INC's top NAICS codes and agencies

NAICS: 811210

Federal

INTENT TO SOLE SOURCE - ABBOTT LABORATORIES

Solicitation # 36C26326P0627

The Department of Veterans Affairs, through its Network Contracting Office 23, intends to award a sole source, firm-fixed price contract to Abbott Laboratories Inc for the service, maintenance, and software support of the EnSite X system. This action is justified under 41 U.S.C. 3304(a)(1) and FAR 13.106-1(b), as the EnSite X system’s service plan is proprietary and no other third-party vendor is authorized to install or service the equipment. The requirement is classified under NAICS code 811210 and product service code J065, and the place of performance is identified as Minneapolis, Minnesota. Although this notice is not a solicitation and does not obligate the government to award a contract, it serves to inform the public of the anticipated sole source award and invites other responsible sources to demonstrate their capability to meet the requirement. Interested vendors may submit capability statements, proposals, or quotations to joseph.bloomer@va.gov no later than seven calendar days after the notice’s publication date of August 6, 2026, with a response deadline of August 16, 2026. The government will evaluate all submissions solely to determine whether the requirement can be met through competitive means, but retains full discretion to proceed with the sole source award regardless of responses received. The contracting officer, Joey Bloomer, may be contacted for further information. No set-aside provisions apply to this action, and the procurement is not open to competitive bidding unless compelling evidence is presented that alternative capable sources exist.

Department Of Veterans Affairs

POSTED

DEADLINE

Solicitation # 36C77026A0003

The Department of Veterans Affairs (VA), through Network Contracting Office 15, awarded a 12-month Blanket Purchase Agreement (BPA) to Bristol-Myers Squibb for the brand-name pharmaceutical REVLIMID® (lenalidomide) capsules, commencing February 2, 2026, and ending February 1, 2027. This BPA was established as a sole-source 8(a) set-aside under GSAM/R 538.7104-3 due to the unique and highly specialized nature of REVLIMID®, which is subject to the FDA-mandated Lenalidomide Risk Evaluation and Mitigation Strategy (REMS) program. The sole source award reflects the clinical necessity of using the brand-name product for certain patients intolerant to generic alternatives and the restrictive distribution requirements that limit supply to REMS-certified pharmacies. The program ensures uninterrupted access to the medication across the VA’s Veterans Integrated Service Networks (VISNs), replacing an expiring McKesson contract. This BPA is situated under Bristol-Myers Squibb's Federal Supply Schedule (FSS) contract and does not include option periods, indicating an interim emergency acquisition to avoid treatment disruptions. The procurement is governed by compliance with REMS-certified dispensing, strict brand-name exclusivity, and FDA requirements, with a focus on patient safety and supply chain reliability. Key administrative contacts include contracting officers and specialists located at the VA contracting office in Leavenworth, KS, while delivery and acceptance occur at VA medical centers and REMS-certified pharmacies nationwide. Pricing details and specific contract values were not disclosed, but the award is based on a best-value trade-off emphasizing regulatory compliance, product uniqueness, and clinical imperatives rather than low cost. Inspection and acceptance rely primarily on adherence to REMS protocols and FDA specifications rather than physical inspection standards. Overall, the contract underscores a specialized federal procurement tailored to the unique pharmaceutical and clinical needs of the Veterans Health Administration.

Department Of Veterans Affairs

POSTED

DEADLINE

Invoice Processing and Payment CoordinationThis contract involves managing the invoicing and payment coordination process for Revlimid® prescriptions following the discontinuation of the McKesson-based invoicing system previously in use. It requires integration with existing Department of Veterans Affairs (VA) systems to ensure a seamless transition and continued efficient handling of prescription billing and payments. The work is classified under NAICS code 541512, which pertains to computer systems design services, indicating a technology-driven solution to support invoicing operations. The contract is a subcontract awarded under the 8(a) Sole Source program, reflecting its status as a specialized arrangement aimed at supporting a veteran-focused federal agency. Specific location details are not provided, suggesting the possibility of a remote or multi-site engagement. This effort is critical to maintaining uninterrupted service delivery for revlimid prescription invoicing within the VA’s healthcare system, emphasizing the importance of technical integration and payment processing accuracy.

Department Of Veterans Affairs

POSTED

DEADLINE

Brand-Name Pharmaceutical Supply (No Substitution)The contract involves the supply of original manufacturer Revlimid® capsules in multiple strengths, ensuring that only brand-name products are provided with no substitutions allowed. This requirement is driven by patient intolerance to generic versions of the medication. The arrangement is designated as a sole-source, brand-only subcontract under the 8(a) set-aside category, reflecting a preference or requirement for a specific supplier due to unique product specifications or circumstances. The Department of Veterans Affairs is the contracting agency, highlighting the focus on providing medications tailored to the needs of veterans who require this specific brand medication. Although specific location details for performance and points of contact are not provided, the contract falls under the NAICS code 325412, which relates to pharmaceutical manufacturing, indicating the nature of the product and supplier. The solicitation was posted on February 6, 2026, emphasizing the urgency and particular nature of the procurement.

Department Of Veterans Affairs

POSTED

DEADLINE

REMS-Certified Specialty Pharmacy DistributionThis contract involves the distribution of the brand-name drug Revlimid® exclusively to Department of Veterans Affairs (VA) patients across the nation. The distribution must be conducted through a specialty pharmacy network that complies with the Risk Evaluation and Mitigation Strategy (REMS) requirements, ensuring strict adherence to safety protocols and oversight. No substitutions with generic or alternative medications are permitted, emphasizing the necessity of dispensing the specified brand-name product. The contract is designated as a subcontract under the NAICS code 424210, which pertains to pharmaceutical preparation and distribution. It is set aside as an 8(a) Sole Source contract, indicating it is awarded without a competitive bidding process under a specific small business development program. The Department of Veterans Affairs is the contracting agency, underscoring its commitment to providing specialized pharmaceutical care to veterans in a highly controlled and compliant manner.

Department Of Veterans Affairs

POSTED

6 months ago

DEADLINE

N/A

View Details